Skip to main content

Table 1 Demographic, serologic, and clinical characteristics of individuals with repeat dengue virus infections

From: Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994–2010

 

All data (n = 502 individuals)a

Cohort extended dataset (n = 205)

Gender

  

Female

252

100

Male

237

95

Unknown

13

10

Age

  

At infection one (mean years ± SD)

7.6 ± 3.0

9.0 ± 1.7

At infection two (mean years ± SD)

11.2 ± 3.0

11.2 ± 2.0

Serologic response at infection one b

  

Primary

84

6

Secondary

263

59

Unknown (symptomatic)

15

-

Unknown (Subclinical/nonhospitalized)

56

56

Unknown (Subclinical)

84

84

Clinical category at infection one c

  

Symp. (DHF)

201

24

Symp. (DHF/hospitalized DF)

16

3

Symp. (hospitalized DF)

123

16

Symp. (non-hospitalized DF)

19

19

Symp. (hospitalized/non-hospitalized DF)

3

3

Subclinical/non-hospitalized

56

56

Subclinical

84

84

Clinical category at infection two c

  

Symp. (DHF)

201

17

Symp. (DHF/hospitalized DF)

13

-

Symp. (hospitalized DF)

112

16

Symp. (non-hospitalized DF)

33

29

Symp. (hospitalized/non-hospitalized DF)

1

1

Subclinical/non-hospitalized

42

42

Subclinical

100

100

  1. a488 individuals had two detected infections; 14 had three detected infections.
  2. bThe serologic response could not be categorized in 155 individuals; 140 could not be categorized because they were either subclinical (n = 84) or had seroconversion outside the active surveillance period in cohort studies (n = 56); 15 were symptomatic but had inadequate samples to determine serologic response.
  3. cSubclinical infections in cohort studies were identified by ≥ four-fold rise in dengue hemagglutination inhibition (HAI) titers without detection of symptomatic infection during the intervening surveillance period. Infections captured outside the active study surveillance period by HAI without a recognized hospitalization were marked as ‘subclinical/non-hospitalized’. Hospitalized cases that did not have sufficient clinical information for clinical categorization were marked ‘DHF/hospitalized DF.’ Four infections categorized as DF but with uncertain hospitalization status were marked as ‘hospitalized/non-hospitalized DF’.